FDA Clearance Tracker · P080012-S028
PROMETRA PROGRAMMABLE IMPLANTABLE PUMP
Last checked: Nov 20, 2026Latest source record: Jul 31, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jul 31, 2015
Approved
Time to decision
74 days
Received May 18, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080012-S028
- Device name
- PROMETRA PROGRAMMABLE IMPLANTABLE PUMP
- Applicant
- Infusyn Therapeutics, LLC
- Applicant location
- Hackettstown, NJ
- Received
- May 18, 2015
- Decided
- Jul 31, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P080012
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Infusyn Therapeutics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.